A detailed history of Venator Management LLC transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Venator Management LLC holds 485,000 shares of TSVT stock, worth $2.4 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
485,000
Previous 325,000 49.23%
Holding current value
$2.4 Million
Previous $1.74 Million 7.42%
% of portfolio
0.57%
Previous 0.51%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$3.6 - $5.79 $576,000 - $926,400
160,000 Added 49.23%
485,000 $1.87 Million
Q1 2024

May 13, 2024

BUY
$3.09 - $6.0 $463,500 - $900,000
150,000 Added 85.71%
325,000 $1.74 Million
Q4 2023

Feb 14, 2024

BUY
$1.57 - $4.58 $274,750 - $801,500
175,000 New
175,000 $747,000

Others Institutions Holding TSVT

About 2seventy bio, Inc.


  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $187M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Venator Management LLC Portfolio

Follow Venator Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Venator Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venator Management LLC with notifications on news.